Combivair Rotacap 200/6mcg is primarily indicated in conditions like Asthma, Crohn’s disease, Dermatosis, Eczema, Rhinitis, Ulcerative colitis, and can also be given in adjunctive therapy as an alternative drug of choice in Less severe asthma, Liver transplant, Ventricular fibrillation, pulseless ventricular tachycardia.
Combivair Rotacap 200/6mcg is contraindicated in conditions like Diabetes mellitus, Glucoma, Hypertension,Osteoporosis, Pu Imonary TB,Fungal or viral respiratory infection.
The severe or irreversible adverse effects of Combivair Rotacap 200/6mcg, which give rise to further complications include peptic ulceration, Osteoporosis, Ocular hypertension, Cushing like features, Suppression of adrenal function. The symptomatic adverse reactions produced by Combivair Rotacap 200/6mcg are more or less tolerable and if they become severe, they can be treated Symptomatically, these include Skin reactions, Insomnia, Irritation of throat, Coughing, Candidiasis, Agitation, GI disturbance.
Combivair Rotacap 200/6mcg should be used with caution in patients with medical history including all illnesses, infections, recent exposures to contagious diseases (e.go chicken pox), glaucoma, cataracts or any allergies, especially of any drug allergy. If patients are switching or have switched within the last 9 months from an oral corticosteroid to an inhaled one and experience loss of appetite, nausea, vomiting, unusual tiredness, headache, fever, dizziness, joint and muscle pain or weight loss, so should contact the doctor, there may need to increase dose of the oral corticosteroid temporarily or start taking it again. Children and teenagers should be monitored for proper growth patterns while using any corticosteroid medicine. This medication should be used only when clearly needed during pregnancy or lactation.